Commentary: endovascular peripheral artery disease treatment: “leaving nothing behind?"

Endovascular treatment of peripheral artery disease (PAD) has become the standard of care for TransAtlantic Inter-Society Consensus II A,B patients, although no evidence exists as to which procedures are preferred for each lesion type, and numerous different approaches could be employed.1 The latest trend in this field is to revascularize the limb without stent deployment by means of angio-modeling,2 atherectomy,3 or drug-coated balloon angioplasty.4 Despite these efforts a certain number of patients with relatively short lesions will experience residual stenosis, elastic recoil, or restenosis and thus require bailout stenting.